Sustained rise in antimicrobial resistance in India: ICMR study
10 September 2022
A big chunk of patients in India may no longer benefit from carbapenem, a powerful antibiotic administered mainly in ICU settings to treat pneumonia and septicemia, as they have developed antimicrobial resistance to it, an ICMR study has found.
The data analysis done between January 1 and December 31, 2021, pointed towards a sustained increase in drug-resistant pathogens, resulting in difficulty to treat certain infections with available medicines, senior Indian Council of Medical Research (ICMR) scientist Dr. Kamini Walia, who led the study, said.
Further reading: Teh Hindu
Author(s): The Hindu
Effective Surveillance
Ambassador Network
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!